Thank you to Marc Odrich, Chief Medical Officer of LENZ Therapeutics, for joining us and discussing the differentiation of Aceclidine as a miotic for the potential treatment of presbyopia. The recent data is very exciting and the Optometrist community is looking forward to following the progress of LENZ!
